This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: Herbert R Brinkman: Innovator in Pharmaceutical Chemistry
Introduction
Herbert R Brinkman is a notable inventor based in Bushkill, PA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative processes in drug development.
Latest Patents
Brinkman holds a patent for a process titled "Process for producing N4-acyl-5'-deoxy-5-fluorocytidine derivatives." This patent describes a method for preparing N4-acyl-5'-deoxy-5-fluorocytidine derivatives by selective deacylation. The process involves reacting a specific compound with a base in an aqueous or inert organic solvent, showcasing Brinkman's expertise in chemical synthesis.
Career Highlights
Brinkman is associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work there has contributed to advancements in drug formulation and development, reflecting his commitment to improving healthcare through innovation.
Collaborations
Throughout his career, Brinkman has collaborated with esteemed colleagues, including Panayiotis Kalaritis and John F Morrissey. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Herbert R Brinkman is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His contributions continue to impact the field, demonstrating the importance of creativity and collaboration in scientific advancement.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile